Stay updated with breaking news from Patent board. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Microfluidic Devices Patent Monitor Market Size, Trends, openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.
The DeFi Education Fund is fighting True Return Systems through the patent office alleging its a “patent troll” that’s suing DeFi protocols with the aim of winning a default judgement.
How the Supreme Court Is Attacking Democracy democracyjournal.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from democracyjournal.org Daily Mail and Mail on Sunday newspapers.
To print this article, all you need is to be registered or login on Mondaq.com. On 5 May 2021, the Department of Intellectual Property (DIP) of Thailand rejected a Thai patent application for a granulated powder tablet containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide, also known as Favipiravir, which is a drug used to treat viral infections including COVID-19. Favipiravir has been used in many countries including Thailand to treat COVID-19 patients. With the spiking numbers of COVID-19 infections, demand for Favipiravir has soared with fears of shortage. As Favipiravir can currently only be imported into the country, Thailand aims to establish a production hub for the Favipiravir tablets to meet